These ASX biotechs are working with the US Department of Defense to bring new drugs to market and have a bright future ahead

Immuron (ASX:IMC) is another company working with US Department of Defence. It also serves as an example of how far a clinical candidate can go when a company works with the US Department of Defence for a number of years https://stocksdownunder.com/article/asx-biotechs-us-department-of-defence/

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.